Diet beverages and the risk of obesity, diabetes, and cardiovascular disease: a review of the evidence

被引:68
|
作者
Pereira, Mark A. [1 ]
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
关键词
beverages; diet; epidemiology; obesity; SUGAR-SWEETENED BEVERAGES; FOOD-INTAKE; METABOLIC SYNDROME; BODY-WEIGHT; CONSUMPTION; ADOLESCENTS; ADULTS; PATTERNS; CHILDREN; TRIAL;
D O I
10.1111/nure.12038
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
"Diet beverage" is a common term used to describe beverages that are sweetened with non-nutritive or artificial sweeteners (ASBs). Marketing strategies often imply that consuming these beverages holds promise for weight control or weight loss. The objective of the present review is to provide a synthesis of the literature on the effects of ASBs on body weight, cardiovascular disease, and type 2 diabetes. Consumption of diet beverages is much lower than that of sugar-sweetened beverages (SSBs), and people trying to lose weight report the highest levels of ASB consumption. To date, prospective observational studies have revealed mixed results, and it appears that reverse causality is a particular problem, since individuals who are at higher risk for weight gain may choose to consume ASBs in an attempt to control their weight or reduce disease risk. As for experimental studies, the evidence currently suggests that obesity risk may be lower when ASBs replace SSBs in the diet. Still, additional evidence from experimental studies is needed to more definitively determine the benefits and risks of frequent ASB consumption. (C) 2013 International Life Sciences Institute
引用
收藏
页码:433 / 440
页数:8
相关论文
共 50 条
  • [31] Plant-based Diet And Risk of Cardiovascular Disease in Patients with Prediabetes And Diabetes
    Zhuang, Pan
    Liu, Xiaohui
    Wan, Xuzhi
    Jiao, Jingjing
    CIRCULATION, 2024, 150
  • [32] Obesity and risk factors for type 2 diabetes and cardiovascular disease in Hispanic children
    Delamater, AM
    Brito, A
    Applegate, B
    Casteleiro, V
    Patino, AM
    Katz, G
    Sabogal, C
    Eidson, M
    Goldberg, R
    DIABETES, 2000, 49 : A85 - A85
  • [33] Diet-derived Lysophosphatidic Acid and Obesity-associated Cardiovascular Disease Risk
    Onono, Fredrick
    Mueller, Paul
    Brandon, J.
    Soman, Sony
    Sunkara, Manjula
    Smyth, Susan
    Morris, Andrew
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
  • [34] The Effect of Synthetic Curcumin Analogues on Obesity, Diabetes and Cardiovascular Disease: A Literature Review
    Lavian, Salime
    Mardaneh, Pegah
    Bagherniya, Mohammad
    Emami, Seyed Ahmad
    Butler, Alexandra E.
    Sahebkar, Amirhossein
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (35) : 3979 - 3992
  • [35] Preeclampsia and the risk of cardiovascular disease later in life - A review of the evidence
    Lee, Geraldine
    Tubby, Jennifer
    MIDWIFERY, 2015, 31 (12) : 1127 - 1134
  • [36] Reducing cardiovascular disease risk with diet
    McCarron, DA
    Reusser, ME
    OBESITY RESEARCH, 2001, 9 : 335S - 340S
  • [37] Cardiovascular disease in obesity: A review of related risk factors and risk-reduction strategies
    Aronne, Louis J.
    Brown, W. Virgil
    Isoldi, Kathy Keenan
    JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (06) : 575 - 582
  • [38] Trends in Obesity and Risk of Cardiovascular Disease
    Ryan Lahey
    Sadiya S. Khan
    Current Epidemiology Reports, 2018, 5 : 243 - 251
  • [39] Childhood Obesity and Cardiovascular Disease Risk
    Stephanie T. Chung
    Andrea Krenek
    Sheela N. Magge
    Current Atherosclerosis Reports, 2023, 25 : 405 - 415
  • [40] Childhood Obesity and Cardiovascular Disease Risk
    Chung, Stephanie T.
    Krenek, Andrea
    Magge, Sheela N.
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (07) : 405 - 415